BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2855305)

  • 1. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
    Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
    Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
    Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
    JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
    Snydman DR
    Rev Infect Dis; 1988; 10 Suppl 3():S554-62. PubMed ID: 2847293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
    Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
    Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
    Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
    Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
    J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHPG (Gancyclovir) improves survival in CMV pneumonia.
    Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
    Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
    Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir treatment of cytomegalovirus disease in immunocompromised children.
    Gudnason T; Belani KK; Balfour HH
    Pediatr Infect Dis J; 1989 Jul; 8(7):436-40. PubMed ID: 2547191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: successful treatment with DHPG.
    Shabtai M; Luft B; Waltzer WC; Anaise D; Rapaport FT
    Transplant Proc; 1988 Jun; 20(3):562-3. PubMed ID: 2837853
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of cytomegalovirus pneumonia.
    Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
    Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
    Keay S; Bissett J; Merigan TC
    J Infect Dis; 1987 Dec; 156(6):1016-21. PubMed ID: 2824621
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of ganciclovir for cytomegalovirus disease.
    Fletcher CV; Balfour HH
    DICP; 1989 Jan; 23(1):5-12. PubMed ID: 2541566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
    Buhles WC; Mastre BJ; Tinker AJ; Strand V; Koretz SH
    Rev Infect Dis; 1988; 10 Suppl 3():S495-506. PubMed ID: 2847286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids.
    Reed EC; Dandliker PS; Meyers JD
    Ann Intern Med; 1986 Aug; 105(2):214-5. PubMed ID: 3014941
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
    Selby P; Powles RL; Jameson B; Stolle K; Tryhorn Y; Stern H
    Lancet; 1986 Jun; 1(8494):1377-8. PubMed ID: 2872484
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus infection in patients with AIDS.
    Drew WL
    J Infect Dis; 1988 Aug; 158(2):449-56. PubMed ID: 2841381
    [No Abstract]   [Full Text] [Related]  

  • 18. DHPG treatment of kidney transplant recipients with severe CMV infection.
    Lang P; Buisson C; Rostoker G; Ben Maadi A; Fruchaud G; Deforge L; Chopin D; Abbou C; Romano P; Fleury J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2084-6. PubMed ID: 2540560
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
    Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
    Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.
    Hecht DW; Snydman DR; Crumpacker CS; Werner BG; Heinze-Lacey B
    J Infect Dis; 1988 Jan; 157(1):187-90. PubMed ID: 2826608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.